Search for a Medicine

  • Medicines
 
 

Showing 41-60 of 75 matching medicines

Product listings were last updated on 19/04/2024
Trade Name Licence Number & Holder Documents
Sandimmun 25mg Soft Capsules
Capsule, soft

Compare
PA0896/027/003
Authorised: 21/03/1988
Novartis Ireland Limited
SPC PIL
Sandimmun 50 mg/ml Concentrate for Solution for Infusion
Concentrate for solution for infusion

Compare
PA0896/027/002
Authorised: 03/10/1984
Novartis Ireland Limited
SPC PIL
Sandimmun 50mg Soft Capsules
Capsule, soft

Compare
PA0896/027/005
Authorised: 16/12/1991
Novartis Ireland Limited
SPC PIL
SANDOSTATIN 100 microgram/1ml, solution for injection/infusion
Solution for injection/infusion

Compare
PA0896/028/002
Authorised: 18/11/1988
Novartis Ireland Limited
SPC PIL
SANDOSTATIN 50 microgram/1 ml, solution for injection/infusion
Solution for injection/infusion

Compare
PA0896/028/001
Authorised: 18/11/1988
Novartis Ireland Limited
SPC PIL
SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion
Solution for injection/infusion

Compare
PA0896/028/003
Authorised: 18/11/1988
Novartis Ireland Limited
SPC PIL
Sandostatin LAR 10 mg powder and solvent for suspension for injection
Powder and solvent for suspension for injection

Compare
PA0896/028/004
Authorised: 13/07/1998
Novartis Ireland Limited
SPC PIL
Sandostatin LAR 20 mg powder and solvent for suspension for injection
Powder and solvent for suspension for injection

Compare
PA0896/028/005
Authorised: 13/07/1998
Novartis Ireland Limited
SPC PIL
Sandostatin LAR 30 mg powder and solvent for suspension for injection
Powder and solvent for suspension for injection

Compare
PA0896/028/006
Authorised: 13/07/1998
Novartis Ireland Limited
SPC PIL
Sanomigran 1.5mg Tablets
Coated tablet

Compare
PA1113/012/002
Authorised: 07/09/1994
Phoenix Labs
SPC
Sanomigran 500 microgram Tablets
Coated tablet

Compare
PA1113/012/001
Authorised: 07/09/1994
Phoenix Labs
SPC
Saphnelo
Concentrate for solution for infusion

Compare
EU/1/21/1623/001
Authorised: 14/02/2022
AstraZeneca AB
SPC PIL IPAR
Sapropterin Dipharma
Powder for oral solution

Compare
EU/1/21/1620/001-003
Authorised: 16/02/2022
Dipharma Arzneimittel GmbH
SPC PIL IPAR
Sapropterin Dipharma
Powder for oral solution

Compare
EU/1/21/1620/004
Authorised: 16/02/2022
Dipharma Arzneimittel GmbH
SPC PIL IPAR
Sapvit-D3 400 IU/drop oral drops, solution
Oral drops, solution

Compare
PA0773/006/001
Authorised: 29/09/2017
Fresenius Kabi Austria GmbH
SPC PIL
Sarclisa
Concentrate for solution for infusion

Compare
EU/1/20/1435/001-003
Authorised: 30/05/2020
Sanofi Winthrop Industrie
SPC PIL IPAR
Sastravi 100mg/25mg/200mg Film-coated Tablets
Film-coated tablet

Compare
PA1986/120/003
Authorised: 26/09/2014
Teva B.V.
SPC PIL
Sastravi 125mg/31.25mg/200mg Film-coated Tablets
Film-coated tablet

Compare
PA1986/120/004
Authorised: 26/09/2014
Teva B.V.
SPC PIL
Sastravi 150mg/37.5mg/200mg Film-coated Tablets
Film-coated tablet

Compare
PA1986/120/005
Authorised: 26/09/2014
Teva B.V.
SPC PIL
Sastravi 175mg/43.75mg/200mg Film-coated Tablets
Film-coated tablet

Compare
PA1986/120/006
Authorised: 26/09/2014
Teva B.V.
SPC PIL